Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 14, 2016Journal of Lipid ResearchOpen Access

Lipoprotein lipase (LPL) acts as the pivotal rate-limiting mediator of hydrolysis of core triglycerides from TG-rich lipoproteins, impacting cardiovascular disease risk, energy balance, and insulin action.

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Authors

RHRobert A. Hegele

Discussion

Loading...

Member takes

Overview

LPL modulation merits clinical exploration; leaves open optimal targeting strategies for CVD risk reduction.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Robert A. Hegele (2016) studied this question.

synapsesocial.com/papers/6a7d176fc7e6f6a50737cd80https://doi.org/10.1194/jlr.c070946
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lipoprotein lipase: from gene to obesity2009 · 875 citations
  2. 2Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis1996 · 1,008 citations
  3. 3Lipoprotein Lipase: A General Review2018 · 10 citations
  4. 4The Importance of Lipoprotein Lipase Regulation in Atherosclerosis2021 · 94 citations
  5. 5Lipoprotein Lipase: Recent Contributions from Molecular Biology1992 · 148 citations